Document:

10-K March 31 2009 Exhibit 10.45

Exhibit 10.45

CONFIDENTIAL TREATMENT REQUESTED

MANUFACTURING SERVICES AND SUPPLY AGREEMENT

THIS MANUFACTURING SERVICES AND SUPPLY AGREEMENT (the "Agreement"), effective this 19th day of February,
2009 ("Effective Date") is made and entered into by and between ADAPTEC, INC., a Delaware corporation
having a place of business at 691 S. Milpitas Blvd., Milpitas, California 95035, on behalf of itself and its Affiliates (collectively,
"ADAPTEC"), and SANMINA-SCI CORPORATION, a Delaware corporation having its principal place of business at
2700 North First Street, San Jose, California 95134, on behalf of itself and its Affiliates (collectively "SANMINA-SCI).
ADAPTEC and SANMINA-SCI are sometimes individually referred to herein as a "Party" and collectively referred to herein as the
"Parties".

RECITALS

The Parties previously entered into an Amendment to the Manufacturing Services and Supply Agreement, Effective Date: May
23, 2007 (the "Amendment"), and intend, by this Agreement to terminate the earlier Manufacturing Services and Supply
Agreement dated December 23, 2005 and the Amendment and replace those with this Agreement.  

The Parties are entering into this Agreement to set forth the terms and conditions pursuant to which ADAPTEC will purchase from
SANMINA-SCI and SANMINA-SCI will manufacture, supply and sell to ADAPTEC, on a non-exclusive basis, products listed on the
attached Exhibit A which may be updated from time to time by the Parties as they agree in writing.

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties
agree as follows:

1.DEFINITIONS

1.1  "ADAPTEC Controlled Components" means those Components for which ADAPTEC negotiates the prices
and confirms lead times with vendors which shall be handled by a consistently updated, mutually agreed list to be reviewed quarterly by
the Parties.  All other Components are SANMINA-SCI Controlled Components.

1.2"Affiliate" means, with respect to any Party, any entity that directly or indirectly controls, is controlled by, or is under
common control with a Party. For purposes of this definition, "control" means having: (i) ownership of more than fifty percent (50%) of
the outstanding voting securities entitled to vote for the election of directors (or, in the case of an entity that is not a corporation, for the
election of the corresponding managing authority); or (ii) the right to vote for or appoint a majority of the board of directors or other
governing body of such entity. An entity will be deemed to be an Affiliate only so long as such control exists.

1.3   "BOM" means bill of materials.

1.4  "Current Product" means any Product that is in production as of December 31, 2008 which is listed on the
attached Exhibit A, as revised by the Parties, from time to time, as the Parties agree in writing.   

1.5  "Delivered Cost" means SANMINA-SCI's quoted cost of Components as stated on the BOM.

1.6 "E&O List" means the written list provided by SANMINA-SCI to ADAPTEC notifying ADAPTEC of
the Excess Components or Obsolete Components in its inventory and their Delivered Cost as described more fully in Section 5.7 plus
[******]% mark-up as described in Section 1.8. 

1.7 "Epidemic Failure" has the meaning set forth in Section 8.7, below.

 

1.8 "Excess Component" means any Component that is not required to meet ADAPTEC's Order or Forecast (always within
Component leadtimes), to which such Component was initially ordered and includes Excess Components resulting from any minimum
buy quantities, tape and reel quantities, and multiples of packaging quantities required by the Vendor less the actual cost (per the BOM)
plus a

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

1

Components margin of [******]% on those Components that are returnable to Vendor (less any cancellation or restocking charges). 

1.9  "Excess Component Liability" means ADAPTEC's liability for
Excess Components.

1.10  "Forecast"  means ADAPTEC's nonbinding forecast (excepting in cases of Component purchases within lead times
which are outside of any [******] week Purchase Agreement Release) for Products for the ensuing nine-month period. This will be a rolling
document issued once per month with significant updates highlighted weekly. 

1.11 "Intellectual Property Rights" means all rights in patents, copyrights, trade secrets, trademarks and other
similar rights.

1.12 "Components" means any raw material, component, part or other item
used in the manufacture of the Products.

1.13  "New Product" means Products in production after December 31, 2008 and which are released with a
new model number and for which the BOM includes 80% new Components. 

1.14  "Manufacturing Specifications" means the written specifications that describe the manner in which a Product is
manufactured and tested, and excludes all other Specifications.

1.15  "Obsolete Component" mean any Component that is not currently used to manufacture a Product (whether as a
result of an ECO or otherwise) and for which there is no demand and the cost of which is the actual cost (per the BOM) of those
Components less the amounts for those Components that are returnable to Vendor (less any cancellation or restocking charges).

1.16  "Order" is a document provided by ADAPTEC that stipulates Product, Pricing, Delivery Point, Validity Period and
Target Quantity and includes a Purchase Agreement Release.  Purchase Agreements require Purchase Agreement Releases to
determine delivery quantity and date.

1.17 "Purchase Agreement" means the nonbinding agreement issued by ADAPTEC to SANMINA-SCI listing
Product, Pricing, Delivery Point, Validity Period and Target Quantity.  

 

1.18 "Purchase Agreement Release" means the  binding document provided by ADAPTEC that determines
delivery quantity and date.  

 1.19  "Products" means Current Products and New Products as described below and listed on the attached
Exhibit A which may be updated from time to time by the Parties as they agree in writing which are manufactured by SANMINA-
SCI.

1.20  "Scheduled Release" means the date on which SANMINA-SCI and ADAPTEC agree Products are
available for delivery and release to ADAPTEC and which will be released only in accordance with the Purchase Agreement
Release.

1.21  "Specifications" means the written specifications that describe the design, functionality, configuration and/or
performance requirements of a Product except for Manufacturing Specifications.

1.22  "Vendor(s)"  mean seller(s) of Components. 

1.23  "Warranty Period" means the period of [******] from the date of manufacture of the Product as
more fully described in Section 8.1.

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

2

TERM

The term of this Agreement commences on the Effective Date and continues for three
(3) years thereafter ("Initial Term") and renews thereafter in 1 year increments ("Renewal
Term," collectively, "Term") unless sooner terminated in accordance with the terms of this Agreement.

3.   APPOINTMENT

ADAPTEC and SANMINA-SCI agree that the Manufacturing Services and Supply Agreement between the Parties, signed
December 23, 2005 ("2005 Agreement") is terminated concurrent with the Effective Date. Notwithstanding Section 11.6 of
the 2005 Agreement, Sections 8, 10.1, 10.2 and 14 of the 2005 Agreement survive termination and remain in full force and effect.
Termination of the 2005 Agreement does not affect the prices of Products listed in Purchase Agreement Releases issued to SANMINA-
SCI by ADAPTEC prior to the Effective Date.   The Parties further agree that SANMINA-SCI will manufacture, supply and sell to
ADAPTEC and ADAPTEC will buy from SANMINA-SCI the Products on a non-exclusive basis during the Term in accordance with this
Agreement. Products will only be manufactured in SANMINA-SCI's Singapore or Batam Plant unless the ADAPTEC otherwise first
agrees in writing which may require adjustment of the financial terms resulting from manufacturing relocation. ADAPTEC may buy the
Products from sources other than SANMINA-SCI.

4.   PRICES AND PAYMENT

4.1.  Prices.  During the Term and subject to Section 3,
above, the prices for all Products will be determined solely in accordance with the terms and conditions set forth in the New Product
MVA Matrix and Current Product MVA Matrix included in the attached Exhibit A.   

4.2  Payment Terms.  ADAPTEC agrees to pay all undisputed amounts included
in SANMINA-SCI's invoice within [******] days after date of the invoice. Late payments for undisputed amounts accrue interest at
the lesser rate of 1.5% per month or maximum amount permitted by law.  Unless otherwise stated, all prices are stated in and all
payments shall be made in U.S. Dollars.  

4.3  Setoffs.  Except as expressly agreed to in writing by the Parties, neither Party shall be entitled to set-off any amount
owing from the other Party to such Party against any amount payable to the other Party from such Party, under this Agreement or
arising out of any other Agreement or transaction between the Parties.  For purposes of this Section 4.6, a Party shall be deemed to
include the Parties to this transaction and each of the Party's Affiliates.

4.4  Credit Limit.  SANMINA-SCI's Credit Department shall provide ADAPTEC with an initial credit limit, which shall be
reviewed (and, if necessary, adjusted) from time to time.  SANMINA-SCI shall have the right to reduce the credit limit upon 10 business
days' prior written notice to ADAPTEC if ADAPTEC has not provided SANMINA-SCI with reasonable assurances in response to its
written request. In the event ADAPTEC exceeds this credit limit or has any outstanding invoice for undisputed amounts more than
fifteen (15) business days after written notice to ADAPTEC has expired and ADAPTEC fails to make any payment, SANMINA-SCI may
stop shipments of Product to ADAPTEC until ADAPTEC makes a sufficient payment to bring its account within the credit limit provided.

4.5Pricing for Small Builds. For purposes hereof, "Small Build" means any Product that ADAPTEC requests
SANMINA-SCI to manufacture in quantities of 300 or less of the same board assembly. For clarification, all Products in any Small Build
must be from the same Product family (i.e., the same PCB) with no builds within the previous two months or no subsequent Orders
looking forward to the next three months. The pricing set forth in Exhibit A will apply to Small Builds; provided,
however, that SANMINA-SCI will be entitled to charge an additional amount for each Small Build to cover its costs in producing small
volume Products  of no more than [******] ("Setup Fee"). SANMINA-SCI will advise ADAPTEC of the amount of the Setup
Fee within five (5) business days after a request from ADAPTEC ("Request").  

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

3

5. FORECAST, PURCHASE ORDERS AND RESCHEDULE 

5.1  Forecast.  (a) ADAPTEC shall provide SANMINA-SCI with a Forecast on a monthly basis for a rolling nine month
period. This Forecast will include an estimated breakdown of Forecasted Product requirements on a weekly basis for the first three
months of the Forecast period. Any quantities listed in any Forecast or other correspondence between the Parties are only estimates
made as an accommodation for planning purposes and do not constitute a commitment on ADAPTEC'S part to purchase such quantity.
ADAPTEC may revise any Forecasts in its sole discretion. Any expenditures or commitments by SANMINA-SCI in anticipation of
ADAPTEC'S requirements are at SANMINA-SCI'S sole risk and expense except as the Parties otherwise expressly agree in this
Agreement.  Within 10 business days  of ADAPTEC providing the monthly Forecast (or as agreed to by the Parties),  SANMINA-SCI will
take all actions to procure, reschedule and cancel SANMINA-SCI's orders for Components. Any action not taken within this time frame
results in SANMINA-SCI's sole liability and responsibility unless the Parties otherwise agree to extend the time.

5.2  Orders. ADAPTEC will issue written Orders and/or Purchase Agreement Releases specifying the number of Products
to be manufactured and shipped during the period covered and other terms as mutually agreed. Orders will cover a [******] week period and
will include, as applicable: (i) the delivery date or shipping schedule; (ii) the location to which the Products are to be shipped; and (iii)
transportation instructions. Each Order and/or Purchase Agreement Release will reference this Agreement. SANMINA-SCI will notify
ADAPTEC of rejection of any Order within three business days after receipt of the date of the Order or the Order is deemed rejected. If
SANMINA-SCI does not accept or reject the Order within the three business day period, the Order shall be deemed rejected by
SANMINA-SCI.  Notwithstanding the foregoing, SANMINA-SCI shall not reject an Order for Forecasted Products (including Upside
Demand). Once accepted by SANMINA-SCI, Orders may not be changed except as otherwise stated herein. The Parties agree that the
terms and conditions contained in this Agreement shall prevail over any terms and conditions of any Purchase Order, acknowledgment
form or other instrument except as such writing is signed by each Party's authorized representative. 

 5.3 Component Liability.     ADAPTEC will be financially responsible for all Components ordered by SANMINA-SCI per
ADAPTEC's Purchase Agreement Release and all Components ordered by SANMINA-SCI per Adaptec's forecast within the then-
current agreed lead-times. 

5.4  Reschedule. ADAPTEC may reschedule all or part of a scheduled delivery at any time which will be communicated
through the Parties' respective designated personnel for up to 60 days from the initial agreed-upon Delivery Date.  SANMINA-SCI shall
use reasonable commercial efforts to accommodate any upside schedule changes beyond the firm Order periods. 

5.5   Meeting Demand for Un-Forecasted Products. Subject to the terms set forth herein and in Exhibit A
SANMINA-SCI will manufacture Products to meet any un-Forecasted demand.

5.6   Upside Demand.  , SANMINA-SCI will commit to manufacture Products having consistent demand  on at least three
consecutive Forecasts  to meet any un-Forecasted demand up to the percentages specified below (the "Upside Demand
Percentage") beyond the quantities set forth in the applicable Forecast, subject to the limitations contained in this
Section:

	
0-7 Days
	
[******]% (of a specified one-Month Demand)

	
8-30 Days
	
[******]% (of a specified one-Month Demand)

	
31-60 Days
	
[******]% (of a specified one-Month Demand)

	
61-90 
	
[******]% (of a specified one-Month Demand)

Any Purchase Price Variance ("PPV") will be settled quarterly when PPV is a result of
un-Forecasted upside requests, "pull-ins" of then-current Forecasts.  All PPVs are subject to audit verification by ADAPTEC.

5.7 Excess and Obsolete Inventory. On a monthly basis utilizing ADAPTEC's current monthly Forecast and
Scheduled Release, SANMINA-SCI shall provide ADAPTEC with the E&O List. The E&O 

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

4

List will contain a comprehensive where-used analysis and rationale for the excess (e.g. MOO, cancelled Order or Forecast, ECO) and list all Obsolete Components and
Excess Components. Within ten (10) business days of receiving SANMINA-SCI's E&O List, ADAPTEC shall advise SANMINA-SCI
of any Component on the E&O List that it believes is not Excess or Obsolete. Within fifteen (15) business days after receiving
SANMINA-SCI's E&O List, SANMINA-SCI and ADAPTEC shall finalize the E&O List, and ADAPTEC shall issue to
SANMINA-SCI an Order for all Components agreed upon in the finalized E&O List or an Order for Product that will consume the
Excess Components. ADAPTEC shall pay SANMINA-SCI its Delivered Cost plus [******]% Component handling mark-up for Components on
the E&O List along with any undisputed liability for Excess Components within forty-five (45) days of the date of invoice. In the
event the Parties cannot agree as to the Components on the E&O List, ADAPTEC shall pay SANMINA-SCI for all non-disputed
Components in accordance with this Section. SANMINA-SCI shall use commercially reasonable efforts to minimize ADAPTEC's
Component Liability by attempting to return Components to the Vendor or using the Components on other Products or on products that
SANMINA-SCI manufactures for third parties in the same manufacturing facility.  ADAPTEC shall be responsible for any Vendor return
charges for Excess or Obsolete Components.

6.DELIVERY AND ACCEPTANCE

6.1 Delivery.   All Product shipments (including shipments made in accordance with Section 8 (Warranty)) shall be Ex
Works (Incoterms 2000), SANMINA-SCI's facility of manufacture (or repair). Title to and risk of loss or damage to the Product shall pass
to ADAPTEC upon SANMINA-SCI's tender of the Product to the common carrier. ADAPTEC shall be the exporter and importer of
record for all shipments of Products, including any repaired or replacement Products. SANMINA-SCI is not the importer or
exporter of the Products. SANMINA-SCI shall mark, pack, package, crate, transport, ship and
store Products to ensure (a) delivery of the Product to its ultimate destination in safe condition, (b) compliance with all requirements of
the carrier and destination authorities, and (c) compliance with any special instructions of ADAPTEC. SANMINA-SCI shall use
reasonable efforts to deliver the Products on the agreed-upon delivery dates and shall use commercially reasonable efforts to notify
ADAPTEC of any anticipated delays.  SANMINA-SCI will pay for expedited shipment for delayed Products if requested by
ADAPTEC.

6.2 Acceptance. Acceptance of the Product shall occur no later than fifteen (15) days after shipment of Product and shall
be based solely on whether the Product passes a mutually agreeable acceptance test procedure or inspection designed to demonstrate
compliance with the Manufacturing Specifications. In the event of conflict between any of the foregoing, the following order of
precedence shall apply: (i) Order as agreed to between ADAPTEC and SANMINA-SCI; (ii) 100% compliance with all Assembly/Test
plan criteria or component drawing (as applicable); (iii) industry-recognized workmanship standard; and (iv) other applicable referenced
documents. Products cannot be rejected based on criteria that were unknown to SANMINA-SCI or based on test procedures that
SANMINA-SCI has not approved or does not conduct. Notwithstanding anything to the contrary, Products shall be deemed accepted if
not rejected within this fifteen-day period. Once a Product is accepted, all Product returns shall be handled in accordance with Article 8
(Warranty). Prior to returning any rejected Product, ADAPTEC shall obtain an Return Material Authorization("RMA") number from
SANMINA-SCI, and shall return such Product in accordance with SANMINA-SCI's instructions; ADAPTEC shall specify the reason for
such rejection in all RMA's. In the event a Product is rejected, SANMINA-SCI shall have a reasonable opportunity to cure any defect
which led to such rejection.

7.  CHANGES

7.1 General. ADAPTEC may upon sufficient notice make changes within the general scope of this Agreement. Such
changes may include, but are not limited to changes in (i) drawings, plans, designs, procedures, Specifications, test specifications or
BOM, (ii) methods of packaging and shipment, (iii) quantities of Product to be furnished, (iv) delivery schedule, or (v) ADAPTEC-
Furnished Items (defined in Section 9.1). All changes other than changes in quantity of Products to be furnished shall be requested and
finalized in an Engineering Change Order ("ECO"). If any such change causes either an increase or decrease in SANMINA-SCI's cost
or the time required for performance of any part of the work under this Agreement (whether changed or not changed by any ECO) the
Prices and/or delivery schedules shall be adjusted in accordance with the Parties' written agreement.

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

5

7.2 ECO's. 

(i)  SANMINA-SCI will respond to [******] ECO requests per quarter for production ECO's and [******] ECO requests per
month for pre-production ECOs without a non-recurring administrative fee. Responses to additional ECO's will incur an administrative
fee of [******] each. Within five (5) business days after an ECO is received, SANMINA-SCI shall advise ADAPTEC in writing (a) of any
change in Prices or delivery schedules resulting from the ECO and (b) the Delivered Cost plus mark-up as indicated in Exhibit A of any
finished Product, Work-in-Process or Components rendered Excess or Obsolete as a result of the ECO (collectively the "ECO
Charge"). Unless otherwise stated, ECO Charges are valid from thirty (30) days from the date of the ECO Charge.

(ii)  In the event ADAPTEC desires to proceed with the change after receiving the ECO Charge pursuant to Section 7.2, ADAPTEC
shall advise SANMINA-SCI in writing and shall immediately pay the portion of the ECO Charge set forth in Section 7.2(i). In the event
ADAPTEC does not desire to proceed with the Change after receiving the ECO Charge, it shall so notify SANMINA-SCI. In the event
SANMINA-SCI does not receive written confirmation of ADAPTEC's desire to proceed with the change within thirty (30) days after
SANMINA-SCI provides ADAPTEC with the ECO Charge, the ECO shall be deemed cancelled.

8.WARRANTY

8.1 SANMINA-SCI Warranty. SANMINA-SCI warrants that, for the Warranty Period, the Products will comply with the
applicable Manufacturing Specifications and shall be free from defects in workmanship.  SANMINA-SCI shall, at its option and at its
expense, repair, replace or issue a credit for Products found defective during the Warranty Period per the remedies described in
Section 8.2. In addition, SANMINA-SCI will pass on to ADAPTEC all Vendors' (and manufacturers') Component warranties to the extent
that they are transferable which does not relieve SANMINA-SCI from its obligations under this Warranty.  In addition, SANMINA-SCI will
be responsible for all reasonable efforts to resolve warranty issues with such Component Vendors including acting as the point of
contact for all warranty related issues and providing RMA support. All warranty obligations will cease upon the expiration of the
Warranty Period except any repaired or replaced Product shall be warranted as set forth in this Section for a period equal to the greater
of (i) the balance of the applicable warranty period relating to such Product or (ii) sixty (60) days after it is received by ADAPTEC. ALL
CLAIMS FOR BREACH OF WARRANTY (EXCLUDING CLAIMS FOR EPIDEMIC FAILURE) MUST BE RECEIVED BY SANMINA-SCI
NO LATER THAN THIRTY (30) DAYS AFTER THE EXPIRATION OF THE WARRANTY PERIOD. 

8.2  Warranty Remedies. For any Products under Warranty that is deemed "un-repairable," SANMINA-SCI will
credit ADAPTEC at the Price paid for the Product.    All returns shall be processed within 15 days of Products received by SANMINA-
SCI.

8.3 RMA Procedure-In-Warranty Repairs. SANMINA-SCI will concur in advance on all Products to be returned for repair
or rework which such concurrence shall be reasonable and timely but in no event later than [******] days from ADAPTEC's request.
ADAPTEC shall obtain a RMA number from SANMINA-SCI prior to return shipment. All returns shall be processed in accordance with
SANMINA-SCI's RMA Procedure in effect as of the Effective Date and which SANMINA-SCI has provided to ADAPTEC prior to the
Effective Date.  Any changes to SANMINA-SCI'S RMA Procedure requires agreement of the Parties. ADAPTEC shall pay all
transportation costs for returns of the Products to SANMINA-SCI and SANMINA-SCI shall pay for the shipment of the repaired or
replacement Products to ADAPTEC, and each shall bear risk of loss or damage to such Products for the leg in transit for which it pays
shipping.  ADAPTEC shall pay all shipping charges, plus a handling charge, for Products returned without an RMA number or "no
defect found" returns. 

8.4 Exclusions From Warranty. The warranties set forth in Section 8.1 do not apply to the extent a failure of a Product to
conform to such warranties results from: (a) ADAPTEC's design including, but not limited to, design functionality failures, specification
inadequacies; (b) accident, disaster, neglect, abuse, misuse, improper handling, storage or installation including improper handling in
accordance with static sensitive electronic device handling requirements by ADAPTEC; (c) alterations, modifications or repairs by
ADAPTEC or third parties not authorized by SANMINA-SCI; or (d) defective ADAPTEC-provided test 

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

6

equipment or test software. In the
event SANMINA-SCI believes that a Product is not covered by the warranty, it shall advise ADAPTEC of the specific reasons therefore
and, where possible, supply ADAPTEC with any failure analysis and/or root cause evaluation which supports its position. 

8.5 Out-Of-Warranty Repairs.  SANMINA-SCI will confirm the Product is no longer covered by the SANMINA-SCI warranty
and, prior to undertaking any repair activities, SANMINA-SCI will provide a cost estimate for repairs which will be provided on a time
and materials basis, using the labor rate  as the  Parties agree quarterly. ADAPTEC will provide authorization to proceed if it so elects.
All returns shall be processed within 20 days of Products received by SANMINA-SCI.  

8.6 Remedy. THIS WARRANTY IS THE SOLE WARRANTY GIVEN BY THE PARTIES TO EACH OTHER AND IS IN
LIEU OF ANY OTHER WARRANTIES EITHER EXPRESS OR IMPLIED. BOTH PARTIES DO NOT MAKE ANY WARRANTIES
REGARDING MERCHANTIBILITY, NONINFRINGEMENT, AND SPECIFICALLY DISCLAIMS ANY SUCH WARRANTY, EXPRESS OR
IMPLIED.

8.7  Epidemic Failure. 

(a) For the purposes of this Agreement, Epidemic Failure will be deemed to have occurred if more than [******] of any
Products manufactured by SANMINA-SCI hereunder fail  during the Warranty Period or sixty days thereafter in a manner attributable to
the same "root cause" within any time period of ninety (90) days or if more than [******]% of any Products manufactured by SANMINA-SCI hereunder fail in a manner attributable to the same "root
cause" within any time period of thirty (30) days. In such event,. In such event, without limiting SANMINA-SCl's obligations and
ADAPTEC's remedies under Sections 8.1 and 8.4,  SANMINA-SCI shall (i) promptly deliver to ADAPTEC a reasonable plan to correct
the problem, (ii)  SANMINA-SCI shall exert its best reasonable efforts to diagnose the problem; and (iii)  SANMINA-SCI shall reimburse
ADAPTEC for any costs or expenses reasonably incurred by ADAPTEC to repair, replace or retrofit the defective Products including but
not limited to the cost of recovery and replacement (or transportation) of such defective Products already sold to and used by
customers, up to an amount not exceeding $[******]. Upon the acceptance of any such plan by ADAPTEC, SANMINA-SCI shall
implement the plan and deliver to ADAPTEC progress reports relating thereto.

         (b)   Upon ADAPTEC's  notification to SANMINA-SCI of an Epidemic Condition:

  

                   (i) ADAPTEC shall have the right to postpone all or part of the shipments of unshipped Product that are affected by the
Epidemic Condition without liability, by giving written notice of such postponement to SANMINA-SCI, pending correction of the
Epidemic Condition.  

                    (ii) SANMINA-SCI will provide ADAPTEC no later than five (5) business days following the Epidemic Condition a
root cause analysis and corrective action plan.  If, after review of the root cause analysis and corrective action plan, ADAPTEC
determines that the Epidemic Condition necessitates a field stocking recall or customer based recall or retrofit, ADAPTEC, without
waiving any other rights or remedies, may then elect to have SANMINA-SCI undertake all action and pay all reasonable costs and
expenses associated with repairing or replacing the affected Product in the field or by return to SANMINA-SCI's expense  within ten
(10) business days from the determination of an Epidemic Condition by ADAPTEC. Alternatively, if SANMINA-SCI agrees to allow
ADAPTEC to elect to perform repairs or make replacements, SANMINA-SCI will reimburse ADAPTEC for all reasonable costs and
expenses ADAPTEC incurs for repair or replacement.  Such Products, parts or upgrades will have the highest shipping priority. 

           (iii)  The remedy for the affected Product will be incorporated in all subsequent Products (unless ADAPTEC otherwise
directs) at no additional charge to ADAPTEC. 

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

7

(c)    If SANMINA-SCI is unable to develop a corrective action plan acceptable to ADAPTEC, or does not adequately take into
account the business interest of ADAPTEC, or SANMINA-SCI refuses to carry out the agreed upon plan, ADAPTEC shall have the
option to: (i) develop and implement such remedy or engage a third party to do so and, in such case, all such implementation costs, risk
of in-transit loss and damages incurred by ADAPTEC shall be borne by SANMINA-SCI;  (ii) cancel orders of Products affected by the
Epidemic Condition without liability and return to SANMINA-SCI all Product affected by such Epidemic Condition for full refund, payable
by SANMINA-SCI within thirty (30) days after receipt of returned Product (with risk of loss or in-transit damage borne by SANMINA-SCI)
and/or (iii) terminate this Agreement without further liability.  

9. ADAPTEC FURNISHED EQUIPMENT AND COMPONENTS WARRANTY, LICENSE AND
OWNERSHIP

9.1 ADAPTEC-Furnished Items. ADAPTEC shall provide SANMINA-SCI with the Product design and related
specifications, applicable regulatory requirements or documentation which are made available to SANMINA-SCI by accessing
ADAPTEC's Agile PDM system.  (collectively the "ADAPTEC-Furnished Items").  

9.2    Licenses.  

(a)  From ADAPTEC.  

       (i)   ADAPTEC grants SANMINA-SCI a limited, non-assignable, non-transferable, non-exclusive license during the Term to
use ADAPTEC's Intellectual Property delivered to SANMINA-SCI by ADAPTEC solely in connection with and to the extent required to
manufacture the Products exclusively for ADAPTEC and to otherwise perform its obligations hereunder.  SANMINA-SCI agrees to use
all Intellectual Property licensed hereunder in accordance with the applicable license agreement or usage guidelines. All Intellectual
Property remains the property of ADAPTEC.  All Intellectual Property licensed to SANMINA-SCI will be listed in the Statement of Work
or other memorandum signed by the Parties. All Intellectual Property will be maintained as Confidential Information. 

                   (ii)   ADAPTEC Trademarks.  For the term of this Agreement and accordance with the terms and conditions
herein, ADAPTEC grants SANMINA-SCI a personal, non-exclusive, non-transferable, royalty-free, worldwide  license to use those
ADAPTEC's trademarks in connection with SANMINA-SCI's manufacturing of  the Product ("ADAPTEC
Trademarks") in accordance with ADAPTEC's guidelines as such guidelines may be amended from time to time in
ADAPTEC's sole discretion and of which it has advised SANMINA-SCI in writing.  SANMINA-SCI (A) agrees to implement modifications
to ADAPTEC Trademark guidelines into any materials created and distributed after receipt of such written notice; (B) acknowledges
ADAPTEC's rights in the ADAPTEC Trademarks and agrees that any use thereof by SANMINA-SCI inures to the sole benefit of
ADAPTEC; and, (C) agrees to not challenge ADAPTEC's ownership or use of any ADAPTEC Trademarks, or apply to register any
ADAPTEC Trademark or mark confusingly similar thereto. Nothing in this Agreement should be construed to grant SANMINA-SCI any
other license or rights in the Trademarks of the other Party.  

(b) From SANMINA-SCI. In all Products manufactured by SANMINA-SCI pursuant to ADAPTEC Orders,
SANMINA-SCI grants ADAPTEC a nonexclusive, worldwide, royalty-free, perpetual license with the right to sublicense  to use, develop,
modify, reproduce, distribute and sublicense SANMINA-SCI's Pre-Existing Intellectual Property only as incorporated in Products and
such other intellectual property as required for ADAPTEC's rights hereunder.  

9.3    Ownership.

(a)  Pre-Existing Intellectual Property Rights.  All Intellectual Property Rights existing prior to the Effective
Date will belong to the Party that owned such rights immediately prior to such date ("Pre-Existing Intellectual Property
Rights").  Neither Party will gain by virtue of this Agreement any rights of 

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

8

 ownership of copyrights, patents, trade secrets,
trademarks or any other intellectual property rights owned by the other.

        (b)  Ownership.  ADAPTEC shall own all right, title, and interest in the copyrights, patents, trade secrets, trademarks
and other intellectual property rights and any derivatives, improvements or modifications thereof, created, conceived, developed, or
prepared by or for ADAPTEC (including by SANMINA-SCI) pursuant to this Agreement ("New Intellectual
Property"). 

10  INDEMNIFICATION AND LIMITATION OF LIABILITY

10.1 SANMINA-SCI's Indemnification. SANMINA-SCI shall indemnify, defend, and hold ADAPTEC and ADAPTEC's
affiliates, shareholders, directors, officers, employees, contractors, agents and other representatives (the "ADAPTEC-Indemnified
Parties") harmless from all third party demands, claims, actions, causes of action, proceedings, suits, assessments, losses,
damages, liabilities, settlements, judgments, fines, penalties, interest, costs and expenses (including all attorneys' and professional fees
and costs) of every kind (each a "Claim," and, collectively "Claims") to the extent of such Claim: (i) is based upon
personal injury or death or injury to property (other than damage to the Product itself, which is handled in accordance with Section 8,
Warranty) to the extent the foregoing is proximately caused by the negligent or willful acts or omissions of SANMINA-SCI or its officers,
employees, subcontractors or agents, breach of this Agreement; (ii) arises or results from the negligence, willful misconduct or breach
of this Agreement by SANIMINA-SCI or its officers, employees, subcontractors or agents; and/or (iii) arises from or relates to any actual
or alleged infringement or misappropriation of any patent, trademark, mask work, copyright, trade secret or any actual or alleged
violation of any other intellectual property rights arising from or in connection with SANMINA-SCI's manufacturing processes, which, as
to all Products, shall include any Warranted Components for which SANMINA-SCI has designed for ADAPTEC.

10.2 ADAPTEC's Indemnification. Except for SANMINA-SCI's indemnification obligation stated in Section 10.1, ADAPTEC
shall indemnify, defend, and hold SANMINASCI and SANMINA-SCI's affiliates, shareholders, directors, officers, employees,
contractors, agents and other representatives (the "SANMINA-SCI-Indemnified Parties") harmless from all third party Claims:
(i) based upon personal injury or death or injury to property to the extent any of the foregoing is proximately caused by ADAPTEC
except to the extent that a Product is defective as a result of SANMINA-SCI's manufacture or design thereof, which as to all Products,
shall include any Warranted In-Sourced Components that SANMINA-SCI has designed for ADAPTEC; (ii) by the negligent or willful acts
or omissions of ADAPTEC or its officers, employees, subcontractors or agents; and/or (iii) arising from or relating to any actual or
alleged infringement or misappropriation of any patent, trademark, mask work, copyright, trade secret or any actual or alleged violation
of any other intellectual property rights arising from or in connection with the Products.

10.3 Procedure. A Party entitled to indemnification pursuant to this Section 10 (the "Indemnitee") shall promptly
notify the other Party (the "Indemnitor") in writing of any Claims covered by this indemnity, shall grant sole control of the
disposition or settlement of any Claim and shall cooperation in the defense or settlement of any Claim. If the Indemnitor fails, within a
reasonable time after receipt of such notice, to assume the defense with counsel reasonably satisfactory to the
Indemnitee or, if in the reasonable judgment of the Indemnitee, a direct or indirect conflict of interest exists between the
Parties with respect to the Claim, the Indemnitee shall have the right to undertake the defense, compromise and settlement
of such Claim for the account and at the expense of the Indemnitor as the Indemnitor agrees.  Notwithstanding the
foregoing, if the Indemnitee in its sole judgment so elects, the Indemnitee may engage counsel at its own expense  without waiving the
Indemnitor's obligation to indemnify and defend.  A Party will not settle a Claim without the consent to the other Party if such settlement
requires the other Party to pay any money or admit to any liability. Notwithstanding the foregoing, if the Indemnitee in its sole judgment
so elects, the Indemnitee employ counsel at its expense, without waiving the Indemnitor's obligation to indemnify and defend.

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

9

10.4 Limitation of Liability. 

IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY INDIRECT, CONSEQUENTIAL,
INCIDENTAL, PUNITIVE OR SPECIAL DAMAGES, OR ANY DAMAGES WHATSOEVER RESULTING FROM LOSS OF USE, DATA
OR PROFITS, EVEN IF SUCH OTHER PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. The foregoing
shall not limit a Party's liability for a breach of its obligations under Section 14.2. IN ADDITION, IN NO EVENT SHALL SANMINA-SCI'S
LIABILITY FOR ALL CLAIMS ARISING OUT OF THIS AGREEMENT EXCEED [******]. THESE LIMITATIONS SHALL APPLY
NOTWITHSTANDING ANY FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY. Notwithstanding the foregoing, the
foregoing cap on liability shall not apply to limit: (i) a Party's obligation to indemnify the other Party against any third party Claim for
personal injury or property damage, (ii) a Party's liability for actual damages required to be paid to any third party as a result of any
infringement claim; or (iii) a Party's liability for a breach of Section 14.2. Nothing herein shall limit ADAPTEC's liability for undisputed
actual damages under Section 11.2.  For clarification, the separate cap stated under Section 8.7 "Epidemic Failure" for out
of warranty Products shall be construed under the terms of that Section and not under the cap provided in this Section
10.4.

11.  TERMINATION

11.1 Termination for Cause. Either Party may terminate this Agreement or an Order hereunder for
default: (i) if the other Party materially breaches this Agreement; provided, however, no termination right shall accrue until thirty (30)
days after the defaulting Party is notified in writing of the material breach and the defaulting Party has failed to cure the alleged breach;
provided that as to any alleged material breach by ADAPTEC of its undisputed payment obligations under Section 4, such
termination right shall accrue after SANMINA-SCI has provided written notice of default and ADAPTEC has failed to cure such default
within 10 business days of receipt of SANMINA-SCI's written notice or provides adequate assurances of performance;
or (ii) the other Party  (a) enters into or file a
petition, arraignment or proceeding seeking an order for relief under the bankruptcy laws of its respective jurisdiction; (b) enters into a
receivership of any of its assets or (c) enters into a dissolution or liquidation of its assets or an assignment for the benefit of its
creditors.

11.2 Termination for Convenience.   ADAPTEC may terminate this Agreement hereunder for any reason upon thirty (30) days' prior written notice and may
terminate any Order hereunder for any reason upon ninety (90) days' (before scheduled shipment) prior written notice. SANMINA-SCI
may terminate this Agreement, in whole or in part, for any reason upon one hundred eighty (180) days' notice.  

11.3  Termination for Force Maieure Event. If, as a result of a Force Majeure Event (defined in Section 13.1), a Party's is
unable to perform for a cumulative period of ninety (90) days, then the other Party, at its option may terminate pending Orders upon five
(5) days notice to the other Party.

11.4Consequences of Termination.

(i)  Termination by SANMINA-SCI for Cause. In the event that SANMINA-SCI terminates this Agreement or an Order
pursuant to Section 11.1 (Termination of Cause), ADAPTEC shall pay SANMINA-SCI termination charges equal to: (1) the Price for all
finished Product existing at the time of termination; and (2) ADAPTEC's Component Liability pursuant to Section 5.3. SANMINA-SCI will
use its best efforts to minimize ADAPTEC's Component Liability which, for the purposes of this subsection, ADAPTEC's Component
Liability shall be calculated based on the quoted cost of Components as stated on the BOM + 4% Components mark-up .

(ii) Termination by SANMINA-SCI for Convenience or Force Majeure Event. If SANMINA-SCI terminates this Agreement
pursuant to Section 11.2 (Termination for Convenience) or Section 11.3 (Force Majeure), ADAPTEC shall pay SANMINA-SCI the Price
for all finished Products delivered or ordered but not yet shipped as of the effective date of termination.

(iii)  Termination by ADAPTEC for Cause; Termination for SANMINA-SCI Force Majeure Event. In the event ADAPTEC
terminates this Agreement or any Order pursuant to Section 11.1 (Termination for Cause) or ADAPTEC terminates this Agreement
pursuant to Section 11.4 (Termination for Force Majeure Event),  

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

10

ADAPTEC shall pay SANMINA-SCI the undisputed Price for (1) all
finished shipped Product and such Products Ordered but not yet shipped .

(v)  Work In Process. In the event of termination for any reason, SANMINA-SCI shall finish all work in process such that
the Product can be shipped as a finished Product as ADAPTEC elects. 

 11.5 Survival. In addition to the obligation to pay any undisputed amounts due and payable prior to the effective date of
termination or expiration, the rights and obligations of the Parties under Sections 1, 4.2, 4.3, 5.3, 5.7, 8, 9.3, 10, 11.5, 14 and 16 will
survive any termination or expiration of this Agreement. 

12  QUALITY

12.1 Specifications. Product shall be manufactured by SANMINA-SCI in accordance with the Specifications, as
modified via written ECO's in accordance with this Agreement, and only at the Singapore or Batam Plant. Neither Party shall make any
change to the Specifications, to any Components described therein, or to the Products (including, without limitation, changes in form, fit,
function, design, appearance or place of manufacture of the Products or changes which would affect the reliability of any of the
Products) unless such change is made in accordance with Section 7.1. Notwithstanding the foregoing, SANMINA-SCI shall be
permitted to make changes in its manufacturing process (not location of manufacture) at any time, so long as such changes do not
affect the form, fit or function of the Products. SANMINA-SCI will inform ADAPTEC of changes to its manufacturing process by means
of a PCN (product change notice).

12.2 Product Content Declaration. SANMINA-SCI will provide a Declaration stating that to the best of SANMINA-SCI's
knowledge, SANMINA-SCI's manufacturing processes are RoHS compliant and compliant with any other mutually agreed
environmental initiatives, laws or directives on a requested and quoted basis. 

12.3 Content of Specifications. The Specifications shall include (as applicable), but shall not be limited to (i) detailed
electrical, mechanical, performance and appearance specifications for each model of Product, (ii) the BOM; (iii) tooling specifications,
along with a detailed description of the operation thereof, (iv) art work drawings, (v) Component specifications, and (vi) Vendor cross
references.

12.4 Components. SANMINA-SCI shall use in its production of Products such Components of a type, quality, and grade
specified by ADAPTEC to the extent ADAPTEC chooses to so specify, and shall purchase Components only from Vendors appearing
on ADAPTEC's approved vendor list ("AVL"); provided, however, that in the event SANMINA-SCI cannot purchase a
Component from a Vendor on ADAPTEC's AVL for any reason, SANMINA-SCI shall be able to purchase such Component from an
alternate Vendor, subject to ADAPTEC's prior written approval, which approval shall not be unreasonably withheld or delayed.
SANMINA-SCI is responsible for managing all Vendors. 

12.5 SANMINA-SCI Components. Notwithstanding the provisions of Section 12.4 or anything in this Agreement to the
contrary, subject to the provisions of this Section 12.5, SANMINA-SCI will have the right, subject to ADAPTEC's prior written approval,
to in-source one hundred percent (100%) of Components, including without limitation, PCBs, Backplane Assemblies, PCBAs,
Enclosures, Cables, Memory Modules, and Optical Modules, if SANMINA-SCI has the capability to do so. SANMINA-SCI will provide
ADAPTEC with such information as ADAPTEC may reasonably request to enable ADAPTEC to confirm that SANMINA-SCI has the
required quality and technology to in-source such Components, as described herein. In addition, and without limiting the generality of
the foregoing, ADAPTEC reserves the right to require qualification and test data of any Components that SANMINA-SCI desires to in-
source. Subject to the foregoing, SANMINA-SCI will inform ADAPTEC if it commences manufacturing of any Products using
Components in sourced by SANMINA-SCI in accordance with the terms hereof. 

12.6 Quality Specifications. SANMINA-SCI shall comply with the quality specifications set forth in the ADAPTEC Quality
Plan provided to SANMINA-SCI on December 20, 2005. 

12.7 Inspection of Facility. Upon reasonable advance written notice ADAPTEC may inspect the 

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

11

 manufacturing processes,
facilities, Products and Components held by SANMINA-SCI for ADAPTEC at SANMINA-SCI's facilities during SANMINA-SCI's regular
business hours, provided that such inspection does not unduly affect SANMINASCI's operations. ADAPTEC and its representatives
shall observe all security and handling measures of SANMINA-SCI while on SANMINA-SCI's premises. If SANMINA-SCI desires to
manufacture Products for ADAPTEC at a facility not previously inspected and qualified by ADAPTEC, SAMINA-SCI will provide
ADAPTEC with a reasonable opportunity to inspect such facility and to undertake any processes deemed reasonably necessary by
ADAPTEC to qualify the facility, including the equipment and the personnel that will be used for the manufacture of Products.

13.  FORCE MAJEURE

13.1 Force Maieure Event. For purposes of this Agreement, a "Force Majeure Event" means the occurrence of
unforeseen circumstances beyond a Party's reasonable control which cannot be avoided by the exercise of due diligence (including the
expenditure of a reasonable sum of money) and does not result from such Party's negligence or intentional misconduct, including, but
not limited to, any act by any governmental authority, act of war, natural disaster, strikes, lockouts or labor disputes by or with any non-
SANMINA-SCI employees, boycott, embargo, riot or civil commotion.

13.2 Notice of Force Maieure Event. Neither Party shall be responsible for any failure to perform due to a Force Majeure
Event provided that such Party gives notice to the other Party of the Force Majeure Event as soon as reasonably practicable,
but not later than five (5) days after the date on which such Party knew or should reasonably have known of the commencement of the
Force Majeure Event, specifying the nature and particulars thereof and the expected duration thereof; provided, however, that
the failure of a Party to give notice of a Force Majeure Event shall not prevent such Party from relying on this Section except to the
extent that the other Party has been prejudiced thereby.

13.3 Termination of Force Maieure Event. The Party claiming a Force Majeure Event shall use reasonable efforts to
mitigate the effect of any such Force Majeure Event and to cooperate to develop and implement a plan of remedial and reasonable
alternative measures to remove the Force Majeure Event (including the expenditure of a reasonable sum of money). Upon the
cessation of the Force Majeure Event, the Party affected thereby shall immediately notify the other Party of such fact, and use its best
efforts to resume normal performance of its obligations under the Agreement as soon as possible. Nothing herein shall require a Party
to settle any labor strikes.

13.4 Limitations. Notwithstanding that a Force Majeure Event otherwise exists, the provisions of this Article shall not
excuse (i) any obligation of either Party, including the obligation to pay money in a timely manner for Product actually delivered or other
liabilities actually incurred, that arose before the occurrence of the Force Majeure Event causing the suspension of performance; or (ii)
any late delivery of Product, equipment, materials, supplies, tools, or other items to the extent caused by negligent acts or omissions on
the part of such Party.

CONFIDENTIALITY

14.1  Definitions. For the purpose of this Agreement, 

 (i)  "Confidential Information" means
information (in any form or media) regarding a Party's customers, prospective customers (including lists of customers and prospective
customers), methods of operation and manufacturing, engineering methods and processes (include any information which may be
obtained by a Party by reverse engineering, decompiling or examining any software or hardware provided by the other Party under this
Agreement), programs and databases, patents and designs, billing rates, billing procedures, vendors and suppliers, business methods,
finances, management, or any other business information relating to such Party (whether constituting a trade secret or proprietary or
otherwise) which has value to such Party and is treated by such Party as being confidential which may be marked as
"confidential" or "proprietary" or which is provided under such circumstances as to reasonably be deemed to be
Confidential Information; provided, however, that Confidential Information does not include information that (a) is rightfully
known to the other Party prior to receipt from the Disclosing Party (as defined below) hereunder, which knowledge shall be evidenced
by written records, (b) is independently developed by the Receiving Party (as defined below), as evidenced by 

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

12

 written records, without
access to any of the Disclosing Party's Confidential Information; (c) is or becomes in the public domain through no breach of this
Agreement, or (d) is received from a third party without breach of any obligation of confidentiality and provided further that Confidential
Information may be disclosed to a Representative or in response to a subpoena, order or other legal, regulatory or compliance
requirement or to a Party's representative.  If disclosure is required pursuant to a subpoena or order of a court or regulatory agency,
Receiving Party will use commercially reasonable efforts to provide prior written notice to the Disclosing Party of the required
disclosure.

(ii) "Person" shall mean and include any individual, partnership, association, corporation, trust,
unincorporated organization, limited liability company or any other business entity or enterprise.

(iii) "Representative" shall  mean  a  Party's  employees,  agents,  or representatives ,including, without
limitation, financial advisors, lawyers, accountants, experts, and consultants.

14.2   Nondisclosure covenants.

(i) In connection with this Agreement, each Party (the "Disclosing Party") may furnish to the other
Party (the "Receiving Party") or its Representatives certain Confidential Information. For a period of three (3) years from
the date of the last disclosure under this Agreement, the Receiving Party: (a) shall maintain as confidential all Confidential Information
disclosed to it by the Disclosing Party, (b) shall not, directly or indirectly, disclose any such Confidential Information to any Person other
than (i) those Representatives of the Receiving Party whose duties justify the need to know such Confidential Information so long as
each Representative is bound by a similar obligation of confidentiality or (ii) if SANMINA-SCI is the Receiving Party, a third party
Vendor for the purpose of obtaining price quotations and (c) shall treat such Confidential Information with the same degree of care as it
treats its own Confidential Information (but in no case with less than a reasonable degree of care).  Notwithstanding the foregoing, trade
secrets and source code shall be held as Confidential Information until falling within an exception listed in 14.1 above.

(ii) The disclosure of any Confidential Information is solely for the purpose of enabling each Party to perform
under this Agreement, and the Receiving Party shall not use any Confidential Information disclosed by the Disclosing Party for any
other purpose.

(iii) Except as otherwise set forth in this Agreement, all Confidential Information supplied by the Disclosing Party
shall remain the property of the Disclosing Party, and will be promptly returned by the Receiving Party upon receipt of written request
therefor.

14.3 Injunctive Relief Authorized. Any material breach of this Article by a Party or its Representatives
may cause irreparable injury and the non-breaching Party may be entitled to equitable relief, including injunctive relief and specific
performance, in the event of a breach. The above will not be construed to limit the remedies available to a Party. In addition, the
prevailing Party will be entitled to be reimbursed for all of its reasonable attorneys' fees and expenses at all levels of proceedings and
for investigations, from the non-prevailing Party.

14.4 No Publicity. Each Party agrees not to issue any press release or make any public announcement
relating to the subject matter of this Agreement without the prior consent of the other Party, except as a Party believes in good faith is
required by applicable law or any listing or trading agreement concerning its publicly-traded securities (in which case, the Party seeking
to disclose the information shall give reasonable notice to the other Party of its intent to make such a disclosure).

15.INSURANCE

SANMINA-SCI agrees to maintain during the term of this Agreement a) workers' compensation insurance
as prescribed by the law of the state in which SANMINA-SCI's services are performed; (b) employer's liability insurance with limits of at
least $500,000 per occurrence; (c) commercial automobile liability insurance if the use of motor vehicles is required, with limits of at
least $1,000,000 for bodily injury and property damage for each occurrence; (d) commercial general liability insurance, including blanket
contractual liability and broad form property damage, with limits of at least $1,000,000 combined single limit for personal injury and
property damage for each occurrence; and (e) commercial general liability insurance endorsed to 

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

13

 include products liability and
completed operations coverage in the amount of $1,000,000 for each occurrence. SANMINA-SCI shall furnish to ADAPTEC certificates
or evidence of the foregoing insurance indicating the amount and nature of such coverage and the expiration date of each policy. Each
Party agrees that it, its insurer(s) and anyone claiming by, through, under or in its
behalf shall have no claim, right of action or right of subrogation against the other Party and the
other Party's affiliates, directors, officers, employees and customers based on any loss or liability insured against under the insurance
required by this Agreement.

16.MISCELLANEOUS

16.1 Audit. SANMINA-SCI agrees to maintain all books and records in accordance with generally accepted
accounting procedures ("GAAP"). In addition to the Right to Inspect Facilities under Section 12.7, ADAPTEC, upon
prior reasonable written notice, may inspect all books and records of SANMINA-SCI to confirm compliance with this Agreement and
SANMINA-SCI agrees to make all such books and records available to ADAPTEC at SANMINA-SCI's principal place of business first
stated in the Introductory Clause to this Agreement or such other location as ADAPTEC agrees. 

16.2 Integration Clause. This Agreement (including the Exhibits and Schedules to this Agreement) constitutes the entire
agreement between the Parties with respect to the subject matter hereof and supersedes any prior understandings, agreements,
warranties or representations by or between the Parties, written or oral, to the extent they related in any way to the subject matter
hereof. The Parties expressly agree the Amendment to the Manufacturing Services and Supply Agreement, Effective Date May 23,
2007 and the Manufacturing Services and Supply Agreement dated December 23, 2005 are terminated in their entireties as of the
Effective Date and replaced with this Agreement. This Agreement may be amended by the Parties hereto at any time by execution of
an instrument in writing signed on behalf of each of the Parties hereto.

16.3 Order of Precedence. All quotations, Orders, acknowledgments and invoices issued pursuant to this Agreement are
issued for convenience of the Parties only and shall be subject to the provisions of this Agreement and the Exhibits hereto. When
interpreting this Agreement, precedence shall be given to the respective parts in the following descending order: (a) this Agreement; (b)
Schedules and Exhibits to this Agreement; and (c) if Orders are used to release Product, those portions of the Order that are not pre-
printed and which are accepted by SANMINA-SCI. The Parties acknowledge that (y) the preprinted provisions on the reverse side of
any such quotation, Order, acknowledgment or invoice and (z) all terms other than the specific terms set forth in Section 5.2 shall be
deemed deleted and of no effect whatsoever.

16.4Waiver. The rights and remedies of the Parties to this Agreement are cumulative and not alternative. Neither the
failure nor any delay by any Party in exercising any right, power or privilege under
this Agreement or the documents referred to in this Agreement will operate as a waiver of such right, power or privilege, and no
single or partial exercise of such right, power, or privilege will preclude any other or further exercise of such right, power, or privilege or
the exercise of any other right, power, or privilege. To the maximum extent permitted by applicable law, (i) no claim or right arising out
of this Agreement or the documents referred to in this Agreement can be discharged by one Party, in whole or in part, by a waiver or
renunciation of the claim or right unless in writing signed by the other Party; (ii) no waiver that may be given by a Party will be
applicable except in the specific instance for which it is given; and (iii) no notice to or demand on one Party will be deemed to be a
waiver of any obligation of such Party or of the right of the Party giving such notice or demand to take further action without notice or
demand as provided in this Agreement or the documents referred to in this Agreement.

16.5  Assignment. This Agreement shall be binding upon and inure to the benefit of the Parties named herein (including
their Affiliates) and their respective successors and permitted assigns. Neither Party may assign or transfer this Agreement or any of its
rights, interests, or obligations hereunder without the prior written approval of the other Party. Notwithstanding the foregoing, either
Party may assign or transfer this Agreement or any of its rights, interests, or obligations hereunder, to a third party that succeeds to all
or substantially all of its assets or related business (whether by sale, merger, operation of law or otherwise), 

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

14

 without the consent of the
non-assigning Party.  The successor in interest is subject to the terms and conditions of this Agreement then in effect.  

16.5 Independent Contractors. In the exercise of their respective rights, and the performance of their respective
obligations under this Agreement, the Parties are, and will remain, independent contractors. Nothing in this Agreement will be construed
(i) to constitute the Parties as principal and agent, partners, joint venturers, or otherwise as participants in a joint undertaking; or (ii) to
authorize a Party to enter into any contract or other binding obligation on the part of the other Party. No Party will represent to any other
person, firm, corporation or other entity that it is authorized to enter into any contract or other binding obligation on behalf of the other
Party.

16.6 Notices. . All notices and other communications required or permitted hereunder shall be in writing, shall be
effective when given, and shall in any event be deemed to be given upon receipt or, if earlier, (a) upon delivery, if delivered by hand, (b)
three business days after the business day of deposit with Federal Express or similar overnight courier, freight prepaid or (c) one
business day after the business day of facsimile transmission, if delivered by facsimile transmission with copy by Federal Express or
similar overnight courier, freight prepaid, and shall be addressed to the intended recipient as set forth below:

If to SANMINA-SCI:

Sanmina-SCI Corporation

2700 North First Street

San Jose, CA 95134

Attention: Sanmina-SCI Sales Manager for Adaptec 

Telephone No.: (408) 964-3500

Facsimile No.: (408) 964-3636

Copy to:

Steven Jackman, Vice President and Corporate Counsel Facsimile:(408) 964-3636

If to ADAPTEC:

ADAPTEC, INC.

691 S. Milpitas Blvd.

Milpitas, California 95035

Attention: Chief Financial Officer

Either Party may change the address to which notices, requests, demands, claims, and other communications hereunder are to be
delivered by giving the other Party ten (10) days' advance written notice to the other Party pursuant to the provisions above.

 16.7 Severability. Any term or provision of this Agreement that is invalid or unenforceable in any situation in any
jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of
the offending term or provision in any other situation or in any other jurisdiction.

 16.8 Construction. The Parties have participated jointly in the negotiation and drafting of this Agreement. In the event an
ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties and no
presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any of the provisions of this
Agreement. Any reference to any federal, state, local, or foreign statute or law shall be deemed also to refer to all rules and regulations
promulgated thereunder, unless the context requires otherwise. The word Including" shall mean including without limitation. Unless the
context requires otherwise, all words used in this Agreement in the singular number shall extend to and include the plural, all words in
the plural number shall extend to and include the singular, and all words in any gender shall extend to and include all genders.

16.9  Headings. The section headings contained in this Agreement are inserted for 

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

15

convenience only and shall not affect
in any way the meaning or interpretation of this Agreement.

16.10 Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original but all
of which together will constitute one and the same instrument.

16.11 Disputes/Choice of Law/Attornevs' Fees. The Parties shall attempt to resolve any disputes between them arising out
of this Agreement through good faith negotiations. In the event the Parties cannot resolve a dispute, the Parties acknowledge and
agree that the competent court in Santa Clara, California (the "Competent Court") (and not any other court in any state or
country) shall have exclusive jurisdiction in connection with this Agreement. Each Party hereby irrevocably submits to the exclusive
jurisdiction of the Competent Court in any action or proceeding arising out of or relating to this Agreement and irrevocably waives any
objection such person may now or hereafter have as to the venue of any such suit, action or proceeding brought in the Competent
Court or that the Competent Court is an inconvenient forum. This Agreement shall be governed in all respects solely by the substantive
laws of the State of California, without regard to conflicts of laws or the choice of law principles of any jurisdiction including the State of
California, and without the need of any Party to establish the reasonableness of the relationship between the laws of the State of
California and the subject matter of this Agreement, and all questions concerning the validity and construction hereof shall be
determined in accordance with the laws of the State of California. If any legal proceeding or other action relating to this Agreement is
brought or otherwise initiated, the prevailing Party shall be entitled to recover reasonable attorneys fees, costs and disbursements (in
addition to any other relief to which the prevailing Party may be entitled). 

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

16

IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be executed effective as of the Effective
Date.

SANMINA-SCI CORPORATIONADAPTEC, INC.

 

	
 

By: /s/ GEORGE KORSON
	
	
 

By: /s/ MARY DOTZ

	
      Signature
	 	
      Signature

	

      George Korson
	
	

     Mary Dotz

	
      Typed Name
	 	
      Typed Name

	

      VP Western Regional Sales
	
	

      Vice President and Chief Financial Officer

	
      Title
	 	
      Title

	

      February 24, 2009
	
	

      February 19, 2009

	
      Date
	 	
      Date

 

Signature Page to Manufacturing Services and Supply Agreement

 

EXHIBITS:

A. Pricing for Adaptec Products
 

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

17

Exhibit A

Pricing for Adaptec Products

 

1. Prices.  The Parties agree the Prices for Products will be determined as follows:

 A. Current Products:  [******]  

No later than the 10th day before the beginning of the second fiscal quarter immediately following the Effective Date
and each fiscal quarter thereafter during the term, Prices will be adjusted as the Parties first agree in writing based on the current
Adaptec Quarterly Revenue, evaluation of the Component cost and Chart 1. 
 

Chart 1 (Current Products).  The following Price Matrix sets the MVA amount for Current (Production Released) Products and the
price to be paid:

	
Adaptec Quarterly Revenue
	
[******]
	
[******]
	
[******]

	
[******]

	
[******]%
	
[******]%
	
As Quoted

	
[******]

	
[******]%
	
[******]%
	
As Quoted

	
[******]

	
[******]%
	
[******]%
	
As Quoted

	
[******]

	
[******]%
	
[******]%
	
As Quoted

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

18

B. New Products[******]  

    [******]  

    [******]

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

19

Chart 2 (New Products). The following Price Matrix sets the MVA amount for New Products:

At Q0

	
Adaptec Quarterly Revenue
	
[******]
	
[******]
	
[******]

	
[******]

	
[******]%
	
[******]%
	
As Quoted

	
[******]

	
[******]%
	
[******]%
	
As Quoted

	
[******]

	
[******]%
	
[******]%
	
As Quoted

	
[******]

	
[******]%
	
[******]%
	
As Quoted

At Q1

	
Adaptec Quarterly Revenue
	
[******]
	
[******]
	
[******]

	
[******]

	
[******]%
	
[******]%
	
As Quoted

	
[******]

	
[******]%
	
[******]%
	
As Quoted

	
[******]

	
[******]%
	
[******]%
	
As Quoted

	
[******]

	
[******]%
	
[******]%
	
As Quoted

At Q2

	
Adaptec Quarterly Revenue
	
[******]
	
[******]
	
[******]

	
[******]

	
[******]%
	
[******]%
	
As Quoted

	
[******]

	
[******]%
	
[******]%
	
As Quoted

	
[******]

	
[******]%
	
[******]%
	
As Quoted

	
[******]

	
[******]%
	
[******]%
	
As Quoted

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

20

Material Cost Reduction for New Products

 C.  For purposes of this Exhibit A, the following definitions apply: 

(i) "Adaptec Quarterly Revenue" is all amounts paid by Adaptec to Sanmina-SCI on a quarterly basis.   

(ii) "MVA" is the amount Adaptec pays to Sanmina-SCI in addition to the BOM Cost for the Product which is
computed as described above and in accordance with the foregoing Charts 1 and 2 to derive the applicable Price for each quarter.

Foreign Exchange

Either Party shall have the right to revise prices
to account for significant variances in the quarterly average exchange rate (in excess of a
[******]% variance from the base rate(s) below during any
given quarter) between the currency in which the pricing is calculated (currently United States Dollars ) and the currency in which
SANMINA-SCI pays for its labor and overhead (primarily Indonesian Rupiah at this time) and Components; provided, that, for
the avoidance of doubt, shortages do not include any shortages in SANMINA-SCI's Inventories resulting from SANMINA-SCI's failure to
order sufficient quantities of Components in accordance with the terms of this Agreement. When determining the amount by which
prices should be adjusted, the Parties agree that (i) the portion of the pricing model representing labor and/or overhead is
[******] percent [******]%) and (ii) the exchange base rate upon which the pricing model is based
is as follows: 

INDONESIAN RUPIAH$1 = IDR 12,755

For purposes of determining the exchange rate variance, the quarterly average exchange rate will be based on the daily average
rate during each Adaptec fiscal quarter.  All exchange rates will be determined by utilizing the daily rates provided at
www.oanda.com, and
averaging them for the applicable Adaptec fiscal quarter.  The rate provided above is as of December 2, 2008; however, the actual
base rate for the term of this Agreement will be set on Effective Date.  Both parties shall agree to the percentage variance within 30
days of each Adaptec fiscal quarter-end, and any claims to a variance payment, credit or debit must be made within 90 days of the
applicable Adaptec fiscal quarter or amounts will be forfeited. 

By means of example, assume that the material cost of a Product is $100 and the selling price of a Product is $110. Assume that
the Dollar devalues by [******]% against the Indonesian Rupiah
such that $1 is now worth IDR[******].  Since labor and
overhead represent six percent of the selling price, the new price of the Product would include an additional $
[******], bringing the selling price to $[******]
which is derived as follows:

	[******]
	[******]
	[******]
	[******]

Conversely, assume the Dollar strengthens by [******]% against the Indonesian Rupiah, such that $1 is now worth
IDR[******].  Since labor and overhead represent
[******]percent of the selling price, the new price of the product
would be reduced by $[******], dropping the selling price to
$[******], which is derived as follows:

	[******]
	[******]
	[******]
	[******]

 

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

21

Current Adaptec Products as of December 31, 2008

 

	
1641200-R
	
AHA-2944UW RoHS KIT

	
1662000-R
	
APA-1480A RoHS KIT

	
1662200JA-R
	
AHA-2930U/JA RTL RoHS KIT

	
1662200-R
	
AHA-2930U RoHS KIT

	
1706600-R
	
AHA-2944UW/SNI RoHS BAG BULK

	
1713900JA-R
	
AHA-2910C/JA RoHS KIT

	
1714200-R
	
AHA-2915C RoHS BAG BULK

	
1718100-R
	
ACK-68 TERM-U320 RoHS

	
1753200-R
	
ACK-SS26-50LD RoHS

	
1772900-R
	
AVA-2906 RoHS KIT PC/MAC

	
1783500JA-R
	
AHA-2940AU/JA RTL RoHS KIT

	
1815700-R
	
ACK-W2H-2M-T RoHS

	
1815800-R
	
ACK-W2L-2M-T RoHS

	
1815900-R
	
ACK-H2H-2M RoHS

	
1816000-R
	
ACK-H2L-2M RoHS

	
1821900JA-R
	
ASC-29160/JA RoHS KIT

	
1821900-R
	
ASC-29160 RoHS KIT

	
1822100JA-R
	
ASC-19160/JA RoHS KIT

	
1822100-R
	
ASC-19160 RoHS KIT

	
1822300JA-R
	
ASC-39160/JA RoHS KIT

	
1822300-R
	
ASC-39160 RoHS KIT

	
1835000JA-R
	
ASC-29160N/JA RoHS KIT

	
1835000-R
	
ASC-29160N RoHS KIT

	
1840900-R
	
ACK-68P-50P RoHS

	
1860300-R
	
ASC-39160/CPQ HPSD RoHS BULK

	
1863700-R
	
ASC-29160LP RoHS KIT

	
1865500-R
	
ASC-29160LP HIGH RoHS BULK

	
1873200-R
	
AVA-2915LP RoHS BULK

	
1873300-R
	
AVA-2930LP RoHS BULK

	
1873400JA-R
	
AVA-2915LP/JA RoHS KIT

	
1873500JA-R
	
AVA-2930LP/JA RoHS KIT

	
1887000-R
	
ASC-29160LP LOW HT BRKT R 50PK

	
1891800EU-R
	
AVA-2904/EFIGS RoHS KIT

	
1937100-R
	
ACK-68V-68V-LVD-1M-U320 RoHS

	
1961900JA-R
	
AAR-2410SA/JA RoHS KIT

	
1961900-R
	
AAR-2410SA RoHS KIT

	
1972100-R
	
ABM-300 RoHS KIT

	
1973200-R
	
ASC-29160/FSC4 RoHS BULK

	
1977700-R
	
ACK-68I5LVD-LP-ROUND-U320 RoHS

	
1982800-R
	
ASC-29160LP/FSC RoHS BULK

	
2015000JA-R
	
AAR-1210SA/JA RoHS KIT

	
2015000-R
	
AAR-1210SA RoHS KIT

	
2016700-E
	
ASR-3225S/128MB/IBM RoHSE FRU

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

22

	
2016800-E
	
ASR-3225S BATTERY RoHSE FRU

	
2017100-R
	
ACK-68I3-LVD-LP-RND-U320 RoHS

	
2029700-R
	
ACK-68I-68E-LVD-LP-RND-U320 R

	
2035400-R
	
ACK-68I5LVD-LP-RND-U320 R 10PK

	
2039300-R
	
ASR-2020ZCR RoHS KIT

	
2054300-R
	
ACK-68I2-LVD-LP-RND-U320 RoHS

	
2060000-R
	
ASC-29320ALP RoHS BULK

	
2060100JA-R
	
ASC-29320ALP-R/JA RoHS KIT

	
2060100-R
	
ASC-29320ALP-R RoHS KIT

	
2060500JA-R
	
ASC-29320A-R/JA RoHS KIT

	
2060500-R
	
ASC-29320A-R RoHS KIT

	
2060900JA-R
	
ASC-39320A-R/JA RoHS KIT

	
2060900-R
	
ASC-39320A-R RoHS KIT

	
2063300-E
	
AAR-2410SA/64/IBM RoHSE OPT KT

	
2063400-E
	
AAR-2410SA/64MB/IBM RoHSE FRU

	
2074000GE-R
	
ICP GDT8546RZ/GE RoHS KIT

	
2074300GE-R
	
ICP GDT8114RZ/GE RoHS KIT

	
2093400-R
	
ASR-2130SLP RoHS KIT

	
2093500-R
	
ASR-2130SLP RoHS SGL

	
2100500-R
	
ATB-100/256/IBM BATTPK RoHSFRU

	
2102600-R
	
ASC-39160 HP/GE RoHS BULK

	
2108900-R
	
ASR-2020S/128/IBM RoHS FRU-2

	
2115900
	
ASC-39160/DELL3 BULK

	
2118700-R
	
ASR-2130SLP/256MB RoHS SGL

	
2118800-R
	
ASR-2230SLP/256MB RoHS SGL

	
2120200-R
	
ASR-2230SLP RoHS KIT

	
2120300-R
	
ASR-2230SLP RoHS SGL

	
2122700-R
	
ABM-400 RoHS KIT

	
2138800-R
	
ACK-68I6LVD-LP-RND-U320 R 10PK

	
2143100-R
	
ASC-29320ALP/NEC RoHS BULK

	
2146100-R
	
ASC-29320ALP KENDAL HIGH R BLK

	
2146200-R
	
ASC-29320ALP KENDAL RoHS FRU

	
2154200-R
	
AAR-2410SA/HITACHI RoHS BULK

	
2166200-R
	
ASC-29320ALP KENDAL RoHS KIT

	
2166400-R
	
ACK-EXT-SAS-1M RoHS

	
2166500-R
	
ACK-EXT-SAS-2M RoHS

	
2166800-R
	
ACK-INT-SAS-1M RoHS

	
2166900-R
	
ACK-INT-SAS-0.5M RoHS

	
2167000-R
	
ACK-INT-SATA-FANOUT-1M RoHS

	
2167100-R
	
ACK-INT-SATA-FANOUT-0.5M RoHS

	
2169300JA-R
	
AAR-2420SA/JA ROHS KIT

	
2169300-R
	
AAR-2420SA ROHS KIT

	
2169400-R
	
AAR-2420SA/256MB ROHS SGL

	
2169900JA-R
	
AAR-2820SA/JA RoHS KIT

	
2169900-R
	
AAR-2820SA RoHS KIT

	
2170000-R
	
AAR-2820SA/256MB RoHS SGL

	
2170200JA-R
	
AAR-1420SA/JA RoHS KIT

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

23

	
2170200-R
	
AAR-1420SA RoHS KIT

	
2170500-R
	
AAR-1420SA RoHS SINGLE

	
2181100-R
	
AAR-1420SA RoHS BULK

	
2181700-R
	
ICP9014RO RoHS KIT

	
2181900-R
	
ICP9024RO RoHS KIT

	
2183300-R
	
ASR-4805SAS RoHS KIT

	
2185600-R
	
ASR-4800SAS/128MB RoHS SGL

	
2185700-R
	
ASR-4800SAS/256MB RoHS SGL

	
2185900-R
	
ASR-4805SAS/256MB RoHS SGL

	
2187500-R
	
ATB-205/32MB/IBM RoHS BULK

	
2187700-R
	
ATB-205/32MB/IBM RoHS FRU

	
2187900-R
	
ATB-200/256MB/IBM RoHS BULK

	
2188000-R
	
ATB-200/256/IBM RoHS OPT KIT

	
2188100-R
	
ATB-200/256MB/IBM RoHS FRU

	
2188200-R
	
ATB-200/256/IBM BATPK RoHS FRU

	
2189200-R
	
ASC-39320A/Dell RoHS FMS Bulk

	
2197200-R
	
ASR-2025ZCR/64MB/HIT RoHS BULK

	
2197400-R
	
ASR-2020ZCR/64MB/HIT RoHS BULK

	
2199900-R
	
ICP9047MA SATA II RAID RoHS KT

	
2200000-R
	
ICP9087MA SATA II RAID RoHS KT

	
2203400-R
	
AAR-2410SALP/64MB/HP RoHS Bulk

	
2203500-R
	
AAR-2420SA/128MB HP RoHS BULK

	
2204200-E
	
ASR-4005SAS/256/IBM2A RoHSE KT

	
2204300-E
	
ASR-4005SAS/256/IBM2A RoHSEFRU

	
2204400-E
	
ASR-4005SAS/IBM2A BATRoHSE FRU

	
2204600-R
	
ASC-29160LP/NEC RoHS BULK

	
2204700-R
	
ASC-29320A/FSC SCSI RoHS BULK

	
2213700-R
	
ABM-500 RoHS KIT

	
2214400-E
	
ASR-4005SAS/256/IBMPIVRoHSE BK

	
2214600-R
	
ACK-INT-SAS-FANOUT-.5M RoHSkit

	
2215100JA-R
	
ASR-2120S/JA RoHS KIT

	
2215100-R
	
ASR-2120S RoHS KIT

	
2215200-R
	
ASR-2120S RoHS SGL

	
2215700-R
	
ASR-2120S/128MB RoHS SGL

	
2216100-R
	
ASR-2120S/64MB/HIT RoHS BULK

	
2216400-R
	
ASC-48300 with I2C HR RoHS Kit

	
2218300-R
	
ABM-600 RoHS KIT

	
2220300-R
	
ASC-44300 RoHS Kit

	
2220600-R
	
ASC-58300 RoHS Kit

	
2224500-R
	
ASC-29160LP/NETAPP RoHS BULK

	
2228800JA-R
	
ASR-5445/JA RoHS Kit

	
2228800-R
	
ASR-5445 RoHS Kit

	
2230100-R
	
ACK-I-SASx4-4SASx1-Pwr 0.5m R

	
2231100-R
	
ACK-E-mSASx4-SASx4-1M R

	
2231200-R
	
ACK-E-mSASx4-SASx4-2M R

	
2231300-R
	
ACK-E-mSASx4-SASx4-4M R

	
2231400-R
	
ACK-E-mSASx4-mSASx4-1M R

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

24

	
2231500-R
	
ACK-E-mSASx4-mSASx4-2M R

	
2237300-R
	
ASR-4805SAS/256MB/IBM RoHS Kit

	
2237500-R
	
ASR-4805SAS/256MB/IBM RoHS FRU

	
2237600-R
	
ABM-600/IBM RoHS OPT KIT

	
2239500-R
	
ASC-29320ALP/PFU RoHS BULK

	
2240900JA-R
	
AAR-1430SA/JA RoHS Kit

	
2240900-R
	
AAR-1430SA RoHS Kit

	
2241000-R
	
AAR-1430SA RoHS Single

	
2244100JA-R
	
ASR-5805/JA RoHS KIT

	
2244100-R
	
ASR-5805 RoHS KIT

	
2244300-R
	
ASR-5805/512MB RoHS Single

	
2244900-R
	
ASR-5445/512MB RoHS SGL

	
2246200-R
	
ASR-4000SAS ROHS SINGLE

	
2246700-R
	
ASC-39320A/DELL FMS RoHS SGL

	
2248000-R
	
ABM-800 RoHS Kit

	
2248700-R
	
ASC-29320LPE RoHS SGL

	
2248800-R
	
ASC-29320LPE RoHS BULK

	
2249100-R
	
ASR-5085/512MB RoHS SGL

	
2250300JA-R
	
ASC-29320LPE/JA RoHS KIT

	
2250300-R
	
ASC-29320LPE RoHS KIT

	
2250900-R
	
ICP5045BL RoHS Kit

	
2251100-R
	
ICP5085BL RoHS Kit

	
2251300-R
	
ICP5125BR RoHS Kit

	
2251500-R
	
ICP5165BR RoHS Kit

	
2251600JA-R
	
ASR-3085/JA RoHS Kit

	
2251600-R
	
ASR-3085 RoHS Kit

	
2251800JA-R
	
ASR-3405/JA RoHS Kit

	
2251800-R
	
ASR-3405 RoHS Kit

	
2251900-R
	
ASR-3405 RoHS Single

	
2252100JA-R
	
ASR-3805/JA RoHS Kit

	
2252100-R
	
ASR-3805 RoHS Kit

	
2252200-R
	
ASR-3805 RoHS Single

	
2252300-R
	
ASR-3805/256MB RoHS Single

	
2252400-R
	
ASR-31205 RoHS Kit

	
2252600-R
	
ASR-31205/256MB RoHS Single

	
2252700-R
	
ASR-31605 RoHS Kit

	
2252900-R
	
ASR-31605/256MB RoHS Single

	
2253000-R
	
AVA-2930LP RoHS Single

	
2253100-R
	
ASC-19160 RoHS Single

	
2253200-R
	
ASC-29160 RoHS Single

	
2253300-R
	
ASC-29160LP RoHS Single

	
2253400-R
	
ASC-29160N RoHS Single

	
2253500-R
	
ASC-29320A-R RoHS Single

	
2253600-R
	
ASC-29320ALP-R RoHS Single

	
2253700-R
	
ASC-39160 RoHS Single

	
2253800-R
	
ASC-39320A-R RoHS Single

	
2253900-R
	
ASC-44300 RoHS Single

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

25

	
2254000-R
	
ASC-48300 I2C HR RoHS Single

	
2254100-R
	
AAR-2410SA RoHS SINGLE

	
2254200-R
	
AAR-2420SA RoHS SINGLE

	
2254300-R
	
AAR-2820SA RoHS SINGLE

	
2255100-R
	
ICP5805BL RoHS Kit

	
2255800-R
	
AAR-1210SA RoHS SINGLE

	
2256600-R
	
ASC-29320LPE/IBM RoHS KIT

	
2256900-R
	
AHA-2930U RoHS Single

	
2257000-R
	
AHA-2940 ULTRA RoHS Single

	
2257100-R
	
ASC-29320LPE/IBM RoHS FRU

	
2258100JA-R
	
ASR-5405/JA RoHS KIT

	
2258100-R
	
ASR-5405 RoHS KIT

	
2258200-R
	
ASR-5405 RoHS Single

	
2258300-R
	
ASR-51245 RoHS Single

	
2258400-R
	
ASR-51245 RoHS Kit

	
2258500-R
	
ASR-51645 RoHS Kit

	
2258600-R
	
ASR-51645 RoHS Single

	
2258700-R
	
ASR-52445 RoHS Single

	
2258800-R
	
ASR-52445 RoHS Kit

	
2258900-R
	
ASC-29320LPE/FSC RoHS BULK

	
2259900-R
	
ASC-29320LPE/LP FSC RoHS BULK

	
2260100-R
	
ASR-2405 RoHS KIT

	
2260200-R
	
ASR-2405 RoHS SGL

	
2260300-R
	
ASR-2045 RoHS SGL

	
2263800-R
	
ABM-800T ROHS KIT

	
563000-R
	
ACK-INT5 RoHS

	
989000-R
	
AHA-2940 ULTRA RoHS KIT

	
2256000-R
	
ASC-1405 RoHS Single

	
2256100-R
	
ASC-1405 RoHS Kit, REV.1F

	
2259500-R
	
ASC-1045 RoHS Single, REV.1C

	
1816200-R
	
ACK-D2H-2M RoHS

	
1831800-R
	
ACK-DB25M-50HDF RoHS

	
1811400-R
	
AVA-2902BE RoHS BAG BULK

	
1697900-R
	
AHA-2910C RoHS BAG BULK

	
2230200-R
	
ACK-I-SASx4-4SASx1-Pwr 1m R

	
2219600-R
	
ACK-I-SATA4x1-SASx4-FO-0.5M R

	
2214700-R
	
ACK-INT-SAS-FANOUT-1M RoHS kit

	
1810100JA-R
	
APA-1460D-L/JA RTL RoHS KIT

	
1807600-R
	
APA-1460D RoHS KIT

	
1680400EU-R
	
APA-1460B/EFIGS RoHS KIT

	
1862900JA-R
	
APA-1480/JA RoHS KIT

	
2227200
	
FRU,Cable-Ext-SAS-1M,S50

_______________________________________________________________________________________________________________________________________________________________________________________________

The symbol [******] is used to indicate that a portion of the
exhibit has been omitted and filed separately with the Securities and Exchange Commission.  Confidential treatment has been
requested with respect to the omitted portion.

26Unassociated Document

    Exhibit
10.1

     

     

     

     

     

    
 

    UNIT
CORPORATION

    

    2000

    

    NON-EMPLOYEE
DIRECTORS'

    

    STOCK
OPTION PLAN

    

    

    

    as

    

    Amended
and Restated

    May
29, 2009

     

     

     

     

     

     

     

    
       

      
        1

      

       

    

    UNIT
CORPORATION

    

    2000

    

    NON-EMPLOYEE
DIRECTORS' STOCK OPTION PLAN

    

    The
purposes of the Unit Corporation 2000 Non-Employee Directors' Stock Option Plan
(the "Plan") are to promote the long-term success of Unit Corporation (the
"Company") by creating a long-term mutuality of interests between the
non-employee Directors and stockholders of the Company, to provide an additional
inducement for such Directors to remain with the Company and to provide a means
through which the Company may attract able persons to serve as Directors of the
Company.

    

    SECTION
I

    Administration

    

    The
Compensation Committee (the "Committee") of the Board of Directors of the
Company (the "Board") shall administer the Plan. All of the members of the
Committee shall be non-employee directors. The Committee shall keep records of
action taken at its meetings. A majority of the Committee shall constitute a
quorum at any meeting, and the acts of a majority of the members present at any
meeting at which a quorum is present, or acts approved in writing by a majority
of the Committee, shall be the acts of the Committee.

    

    The
Committee shall interpret the Plan and prescribe such rules, regulations and
procedures in connection with the operations of the Plan, as it shall deem to be
necessary and advisable for the administration of the Plan consistent with the
purposes of the Plan. All questions of interpretation and application of the
Plan, or as to stock options granted under the Plan, shall be subject to the
determination of the Committee, which shall be final and binding.

    

    Notwithstanding
the above, the selection of the Directors to whom stock options are to be
granted, the timing of such grants, the number of shares subject to any stock
option, the exercise price of any stock option, the periods during which any
stock option may be exercised and the term of any stock option shall be as
hereinafter provided, and the Committee shall have no discretion as to such
matters.

    

    SECTION
2

    Shares
Available under the Plan

    

    The
aggregate number of shares which may be issued or delivered and as to which
grants of stock options may be made under the Plan is 510,000 shares of Common
Stock, $.20 par value, of the Company (the "Common Stock"), subject to
adjustment and substitution as set forth in Section 5. If any stock option
granted under the Plan is cancelled by mutual consent or terminates or expires
for any reason without having been exercised in full, the number of shares
subject thereto shall again be available for purposes of the Plan. The shares
which may be issued or delivered under the Plan may be 

     

    
       

      
        2

      

       

      either
authorized but unissued shares or reacquired shares or partly each, as shall be
determined from time to time by the Board.

    

    

    SECTION
3

    Grant
of Stock Options

    

    On the
first business day following the day of each annual meeting of the stockholders
of the Company, each person who is then a member of the Board and who is not
then an employee of the Company or any of its subsidiaries (a "non-employee
Director") shall automatically and without further action by the Board or the
Committee be granted a stock option to purchase 3,500 shares of Common Stock,
subject to adjustment and substitution as set forth in Section 5. If the number
of shares then remaining available for the grant of stock options under the Plan
is not sufficient for each non-employee Director to be granted an option for
3,500 shares of common stock (or the number of adjusted or substituted shares
pursuant to Section 5), then each non-employee Director shall be granted an
option for a number of whole shares equal to the number of shares then remaining
available divided by the number of non-employee Directors, disregarding any
fractions of a share.  Solely for purposes of satisfying a deficiency
of shares available for the grant of stock options available to non-employee
Directors on the day after the 2009 annual meeting of the Company’s
stockholders, in addition to the 437 shares available for the grant of options
made to each non-employee Director on May 7, 2009, each non-employee Director
shall receive an additional grant of stock options for 3,063 shares on May 29,
2009, provided, however, that none of these options for 3,063 additional shares
(the “2009 Option Award Balance”) shall vest unless and until this Plan is
approved by the Company’s stockholders. In the event such stockholder approval
in not obtained, then each 2009 Option Award Balance shall be
forfeited.

    

    SECTION
4

    Terms
and Conditions of Stock Options

    

    Stock
options granted under the Plan shall be subject to the following terms and
conditions:

    

    (A)           The
purchase price at which each stock option may be exercised (the "option price")
shall be one hundred percent (100%) of the fair market value per share of the
Common Stock covered by the stock option on the date of grant, determined as
provided in Section 4(G). Notwithstanding any other provision of this Plan, the
purchase price of an outstanding option shall not be subject to modification or
amendment subsequent to the date of grant of such option.

    

    (B)           The
option price for each stock option shall be paid in full upon exercise and shall
be payable in cash in United States dollars (including check, bank draft or
money order). Provided, however, that in lieu of such cash the person exercising
the stock option may pay the option price in whole or in part by delivering to
the Company shares of the Common Stock having a fair market value on the date of
exercise of the stock option, determined as provided in Section 4(G) equal to
the option price for the shares being purchased; except that (i) any portion of
the option price representing a 

     

    
       

      
        3

      

       

    

    fraction
of a share shall in any event be paid in cash and (ii) no shares of the Common
Stock which have been held for less than six months may be delivered in payment
of the option price of a stock option. The date of exercise of a stock option
shall be determined under procedures established by the Committee, and, as of
the date of exercise the person exercising the stock option shall be considered
for all purposes to be the owner of the shares with respect to which the stock
option has been exercised. Payment of the option price with shares shall not
increase the number of shares of the Common Stock, which may be issued or
delivered under the Plan as provided in Section 2.

    

    (C)           No
stock option shall be exercisable during the first six months of its term except
in case of death as provided in Section 4(E), provided, however, that no 2009
Option Award Balance shall be exercisable under any circumstance until after
approval of this Plan by the Company’s stockholders. Subject to the terms of
Section 4(E) providing for earlier termination of a stock option, no stock
option shall be exercisable after the expiration of ten years from the date of
grant. A stock option to the extent exercisable at any time may be exercised in
whole or in part.

    

    (D)           No
stock option shall be transferable by the grantee otherwise than by will, or if
the grantee dies intestate, by the laws of descent and distribution of the state
of domicile of the grantee at the time of death. All stock options shall be
exercisable during the lifetime of the grantee only by the grantee or the
grantee's guardian or legal representative.

    

    (E)           If
a grantee ceases to be a Director of the Company, any outstanding stock options
held by the grantee shall be exercisable and shall terminate, according to the
following provisions:

    

    
      	
              (i)  

            	
              If
      a grantee ceases to be a Director of the Company for any reason other than
      retirement, disability, resignation, removal for cause or death, any then
      outstanding stock option held by such grantee shall be exercisable by the
      grantee (but only to the extent exercisable by the grantee immediately
      prior to ceasing to be a Director) at any time prior to the regular
      expiration date of such stock option or within one year after the date the
      grantee ceases to be a Director, whichever is the shorter
      period.

            

    

    

    
      	
              (ii)  

            	
              If
      during his or her term of office as a Director a grantee is removed from
      office for cause, any outstanding stock option held by the grantee which
      is not exercisable by the grantee immediately prior to removal shall
      terminate as of the date of removal, and any outstanding stock option held
      by the grantee which is exercisable by the grantee immediately prior to
      removal shall be exercisable by the grantee at any time prior to the
      regular expiration date of such stock option or within 30 days after the
      date of removal, whichever is the shorter
  period.

            

    

    

    
      	
              (iii)  

            	
              If
      a grantee ceases to be a Director of the Company by reason of death,
      retirement, resignation or disability, any then outstanding stock option
      

            

    

     

    
       

      
        4

      

      
        
        

      

    

    
      	
               

            	
              
                held
      by such grantee shall be exercisable by the grantee (but in the case of
      resignation, retirement or disability only to the extent exercisable by
      the grantee immediately prior to ceasing to be a Director and in the case
      of death whether or not exercisable by the grantee immediately prior to
      death) at any time prior to the regular expiration date of such stock
      option or within 24 months after the date the grantee ceases to be a
      Director, whichever is the shorter period. In the event of the death of
      the grantee, the stock options shall be exercisable by the person entitled
      to do so under the Will of the grantee, or, if the grantee fails to make
      testamentary disposition of the stock options or shall die intestate, by
      the legal representative of the
grantee.

              

            

    (F)           All
stock options shall be confirmed by an agreement, or an amendment thereto, which
shall be executed on behalf of the Company by the Chief Executive Officer (if
other than the President), the President or any Vice President and by the
grantee.

    

    (G)           Fair
market value of the Common Stock shall be the mean between the following prices,
as applicable, for the date as of which fair market value is to be determined as
quoted in The Wall Street Journal (or in such other reliable publication as the
Committee, in its discretion, may determine to rely upon): (a) if the Common
Stock is listed on the New York Stock Exchange, the closing price per share of
the Common Stock as quoted in the NYSE-Composite Transactions listing for such
date, (b) if the Common Stock is not listed on such exchange, the highest and
lowest sales prices per share of Common Stock for such date on (or on any
composite index including) the principal United States securities exchange
registered under the Securities Exchange Act of 1934 (the "1934 Act") on which
the Common Stock is listed, or (c) if the Common Stock is not listed on any such
exchange, the highest and lowest sales prices per share of the Common Stock for
such date on the National Association of Securities Dealer Automated Quotations
System or any successor system then in use ("NASDAQ"). If there are no such sale
price quotations for the date as of which fair market value is to be determined
but there are such sale price quotations within a reasonable period both before
and after such date, then fair market value shall be determined by taking a
weighted average of the means between the highest and lowest sales prices per
share of the Common Stock as so quoted on the nearest date before and the
nearest date after the date as of which fair market value is to be determined.
The average should be weighted inversely by the respective number of trading
days between the selling dates and the date as of which fair market value is to
be determined. If there are no such sale price quotations on or within a
reasonable period both before and after the date as of which fair market value
is to be determined, then fair market value of the Common Stock shall be the
mean between the bona fide bid and asked prices per share of Common Stock as so
quoted for such date on NASDAQ, or if none, the weighted average of the means
between such bona fide bid and asked prices on the nearest trading date before
and the nearest trading date after the date as of which fair market value is to
be determined, if both such dates are within a reasonable period. The average is
to be determined in the manner described above in this Section
4(G).

    

    
       

      
        5

      

       

    

    (H)           The
obligation of the Company to issue or deliver shares of the Common Stock under
the Plan shall be subject to (i) the effectiveness of a registration statement
under the Securities Act of 1933, as amended, with respect to such shares, if
deemed necessary or appropriate by counsel for the Company, (ii) the condition
that the shares shall have been listed (or authorized for listing upon official
notice of issuance upon each stock exchange, if any, on which the Common Stock
shares may then be listed and (iii) all other applicable laws, regulations,
rules and orders which may then be in effect.

     

    
      (I)            
Forfeiture of Stock Options. If at any time during grantee’s tenure as a
Director,  the Committee determines that grantee has engaged in any
activity in competition with any activity of the company or its subsidiaries, or
activity or conduct that is inimical, contrary or harmful to the interests of
the company or its subsidiaries, including but not limited to:

    

     

    
      	
              (i)  

            	
              conduct
      relating to a Director’s duties to the company for which either criminal
      or civil penalties against the Director may be
  sought;

            

    

     

     

    
      	
              (ii)  

            	
              conduct
      or activity that results in the termination of a Director’s tenure because
      of his or her: (a) failure to abide by the Company’s rules and regulations
      governing the transaction of its business, including without limitation,
      its Code of Business Ethics and Conduct; (b) inattention to duties, or the
      commission of acts while in the position of director which acts amount to
      gross negligence or misconduct; (c) misappropriation of funds or property
      of  the Company or its subsidiaries or committing any fraud
      against the Company or any of its subsidiaries or against any other person
      or entity while serving as a Director of the Company, or (d)
      misappropriation of any corporate opportunity, or otherwise obtaining
      personal profit from any transaction which is adverse to the interests of
      the Company or any of its subsidiaries or to the benefits of which the
      Company or its subsidiaries are entitled; or (e) the commission of a
      felony or other crime involving moral
turpitude;

            

    

     

     

    
      	
              (iii)  

            	
              accepting
      employment with, acquiring a 5% or more equity or participation interest
      in, serving as a consultant, advisor, director or agent of, directly or
      indirectly soliciting or recruiting any employee of the Company or any of
      its subsidiaries who was employed at any time during the Director’s tenure
      with the Company or any of its subsidiaries, or otherwise assisting in any
      other capacity or manner any company or enterprise that is directly or
      indirectly in competition with or acting against the interests of the
      Company or any of its subsidiaries (a "competitor"),
      except for (a) any isolated, sporadic accommodation or assistance provided
      to a competitor, at its request, by the Director during his or her tenure
      with the Company, but only if provided in the good faith and reasonable
      belief that such action would benefit the Company or any of its
      subsidiaries by promoting good business relations with the competitor and
      would not harm the Company’s or any of its subsidiaries’ interests in any
      substantial manner or (b) any other service or assistance that is provided
      at the request or with the written permission of the Company or any of its
      subsidiaries;

            

    

     

     

    
      	
              (iv)  

            	
              disclosing
      or misusing any confidential information or material concerning the
      Company or any of its subsidiaries;
or

            

    

     

    
       

      
        6

      

       

    

    
      	
              (v)  

            	
              making
      any statement or disclosing any information to any customers, suppliers,
      lessors, lessees, licensors, licensees, regulators, employees or others
      with whom the Company or any of its subsidiaries engages in business that
      is defamatory or derogatory with respect to the business, operations,
      technology, management, or other employees of the Company or any of its
      subsidiaries, or taking any other action that could reasonably be expected
      to injure the Company or any of its subsidiaries in their business
      relationships with any of the foregoing parties or result in any other
      detrimental effect on the Company or any of its
    subsidiaries;

            

    

     

     

    then on
the date on which the Director breached this Section 4 (I) as determined by the
Committee and (a) all of the Director’s vested stock options acquired under this
Plan (or other securities into which those stock options have been exercised,
converted or exchanged) shall be returned to the Company or, if no longer held
by the director, and the director shall pay to the Company, without interest,
all cash, securities or other assets received by him or her on the sale or
transfer of such stock or securities, and (ii) all unvested stock options shall
be forfeited.

     

    
      	
              (vi)  

            	
              If
      a Director owes any amount under the above subsections of this Section 4,
      the Company may, to the fullest extent permitted by applicable law, deduct
      such amount from any amounts the Company owes the Director from time to
      time for any reason (including without limitation amounts owed as fees,
      reimbursements or other compensation, or fringe
  benefits).

            

    

     

    

    Subject to the foregoing provisions of
this Section 4 and the other provisions of the Plan, any stock option granted
under the Plan may be subject to such restrictions and other terms and
conditions if any, as shall be determined, in its discretion, by the Committee
and set forth in the agreement referred to in Section 4(F), or an amendment
thereto.

    

    SECTION
5

    Adjustment
and Substitution of Shares

    

    If a
dividend or other distribution shall be declared upon the Common Stock payable
in shares of the Common Stock, the number of shares of the Common Stock set
forth in Section 3, the number of shares of the Common Stock then subject to any
outstanding stock options and the number of shares of the Common Stock which may
be issued or delivered under the Plan but are not then subject to outstanding
stock options shall be adjusted by adding thereto the number of shares of the
Common Stock which would have been distributable thereon if such shares had been
outstanding on the date fixed for determining the stockholders entitled to
receive such stock dividend or distribution.

    

    If the
outstanding shares of the Common Stock shall be changed into or exchangeable for
a different number or kind of shares of stock, other securities or other
property of the Company or another corporation, whether through reorganization,
reclassification, recapitalization, stock split-up, combination of shares,
merger or consolidation, then there shall be substituted for each share of the
Common Stock set forth in Section 3, for each share of the Common Stock subject
to any then outstanding 

     

    
       

      
        7

      

       

      stock
option, and for each share of the Common Stock which may be issued or delivered
under the Plan but which is not then subject to any outstanding stock option,
the number and kind of shares of stock or other securities into which each
outstanding share of the Common Stock shall be so changed or for which each such
share shall be exchangeable.

    

    

    In case
of any adjustment or substitution as provided for in this Section 5, the
aggregate option price for all shares subject to each then outstanding stock
option prior to such adjustment or substitution shall be the aggregate option
price for all shares of stock or other securities (including any fraction) to
which such shares shall have been adjusted or which shall have been substituted
for such shares. Any new option price per share shall be carried to at least
three decimal places with the last decimal place rounded upwards to the nearest
whole number.

    

    No
adjustment or substitution provided for in this Section 5 shall require the
Company to issue or deliver or sell a fraction of a share or other security.
Accordingly, all fractional shares or other securities, which result from any
such adjustment or substitution, shall be eliminated and not carried forward to
any subsequent adjustment or substitution.

    

    SECTION
6

    Effect
of the Plan on the Rights of Company and Stockholders

    

    Nothing
in the Plan, in any stock option granted under the Plan, or in any stock option
agreement shall confer any right to any person to continue as a Director of the
Company or interfere in any way with the rights of the stockholders of the
Company or the Board of Directors to elect and remove Directors.

    

    SECTION
7

    Amendment
and Termination

    

    The right
to amend the Plan at any time and from time to time and the right to terminate
the Plan at any time are hereby specifically reserved to the Board; provided
always that no such termination shall terminate any outstanding stock options
granted under the Plan; and provided further that no amendment of the Plan shall
(a) be made without stockholder approval if stockholder approval of the
amendment is at the time required for stock options under the Plan to qualify
for the exemption from Section 16(b) of the 1934 Act provided by Rule 16b-3 or
by the rules of any stock exchange on which the Common Stock may then be listed,
(b) amend more than once every six months the provisions of the Plan relating to
the selection of the Directors to whom stock options are to be granted, the
timing of such grants, the number of shares subject to any stock option, the
periods during which any stock option may be exercised and the term of any stock
option other than to comport with changes in the Internal Revenue Code of 1986
or the rules and regulations thereunder, (c) otherwise amend the Plan in any
manner that would cause stock options under the Plan not to qualify for the
exemption provided by Rule 16b-3 or (d) modify or amend the purchase price of
any outstanding option No amendment or termination of the Plan shall, without
the written consent of the holder of a 

     

    
       

      
        8

      

       

      stock
option theretofore awarded under the Plan, adversely affect the rights of such
holder with respect thereto.

    

    

    Notwithstanding
anything contained in the preceding paragraph or any other provision of the Plan
or any stock option agreement, the Board shall have the power to amend the Plan
in any manner deemed necessary or advisable for stock options granted under the
Plan to qualify for the exemption provided by Rule 16b-3 (or any successor rule
relating to exemption from Section 16(b) of the 1934 Act), and any such
amendment shall, to the extent deemed necessary or advisable by the Board, be
applicable to any outstanding stock options theretofore granted under the Plan
notwithstanding any contrary provisions contained in any stock option agreement.
In the event of any such amendment to the Plan, the holder of any stock option
outstanding under the Plan shall, upon request of the Committee and as a
condition to the exercisability of such option, execute a conforming amendment
in the form prescribed by the Committee to the stock option agreement referred
to in Section 4(F) within such reasonable time as the Committee shall specify in
such request.

    

    SECTION
8

    Effective
Date and Duration of Plan

    

    The
effective date of the Plan shall be the date of its approval by the stockholders
of the Company and it shall end on May 30, 2017. Notwithstanding any other
provisions contained in the Plan other than the 2009 Option Award Balances, no
stock option shall be granted under the Plan until after such stockholder
approval. No stock option may be granted under the Plan subsequent to May 30,
2017.

    

    IN
WITNESS WHEREOF the Board of Directors as of the 29th day of
May, 2009 has adopted this Plan.

    

    UNIT CORPORATION

    

    

    

    By:          /s/ John G. Nikkel 

    John G. Nikkel

    Chairman of the Board

    of Directors

    [Corporate Seal]

    

    ATTEST:

    

    

    

    /s/
Mark E. Schell

    Mark E.
Schell, Secretary

    
9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00159-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00159-of-00352.parquet"}]]